Bonnie F. Sloane - Publications

Cancer Biology Wayne State University, Detroit, MI, United States 
Molecular Biology, Cell Biology, Pharmacology, Oncology, Biochemistry

208 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ji K, Zhao Z, Sameni M, Moin K, Xu Y, Gillies RJ, Sloane BF, Mattingly RR. Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer. Cancers. 13. PMID 34885152 DOI: 10.3390/cancers13236044  0.312
2020 Thakur A, Kondadasula SV, Ji K, Schalk DL, Bliemeister E, Ung J, Aboukameel A, Casarez E, Sloane BF, Lum LG. Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE). Cancer Immunology, Immunotherapy : Cii. PMID 32865605 DOI: 10.1007/S00262-020-02692-8  0.443
2019 Ji K, Sameni M, Osuala K, Moin K, Mattingly RR, Sloane BF. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer. Cancer Metastasis Reviews. PMID 31605250 DOI: 10.1007/S10555-019-09810-8  0.439
2019 Osuala KO, Ji K, Mattingly RR, Sloane BF. Breast Cancer: Proteolysis and Migration. Advances in Experimental Medicine and Biology. 1152: 401-411. PMID 31456196 DOI: 10.1007/978-3-030-20301-6_21  0.505
2019 Ji K, Mayernik L, Moin K, Sloane BF. Acidosis and proteolysis in the tumor microenvironment. Cancer Metastasis Reviews. PMID 31069574 DOI: 10.1007/S10555-019-09796-3  0.469
2019 Thakur A, Yarlagadda S, Ji K, Schalk DL, Ung J, Bliemeister ET, Aboukameel A, Casarez E, Sloane BF, Lum LG. Abstract 5036: Induction of highly efficacious anti-tumor activity and modulation of tumor microenvironment: Cell-free off the shelf therapeutic modality Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5036  0.426
2018 Shah S, Brock EJ, Jackson RM, Ji K, Boerner JL, Sloane BF, Mattingly RR. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia (New York, N.Y.). 20: 951-963. PMID 30144784 DOI: 10.1016/J.Neo.2018.07.002  0.433
2018 Brock EJ, Ji K, Shah S, Mattingly RR, Sloane BF. In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ. Journal of Mammary Gland Biology and Neoplasia. PMID 30056557 DOI: 10.1007/S10911-018-9405-3  0.392
2018 Brock EJ, Jackson R, Boerner JL, Li Q, Sloane BF, Mattingly RR. Abstract B14: Sprouty4 regulates the transition to invasive breast ductal carcinoma through ERK/MAPK signaling Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B14  0.4
2018 Ji K, Zhao Z, Moin K, Xu Y, Gillies RJ, Mattingly RR, Sloane BF. Abstract 2131: Paracrine cytokine pathways mediate metastasis of breast cancer to lymphatics Cancer Research. 78: 2131-2131. DOI: 10.1158/1538-7445.Am2018-2131  0.456
2017 Duivenvoorden HM, Rautela J, Edgington-Mitchell LE, Spurling A, Greening DW, Nowell CJ, Molloy TJ, Robbins E, Brockwell NK, Lee CS, Chen M, Holliday A, Selinger CI, Hu M, Britt KL, ... ... Sloane BF, et al. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion. The Journal of Pathology. PMID 29086922 DOI: 10.1002/Path.4990  0.471
2017 Sameni M, Cavallo-Medved D, Franco OE, Chalasani A, Ji K, Aggarwal N, Anbalagan A, Chen X, Mattingly RR, Hayward SW, Sloane BF. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Research : Bcr. 19: 56. PMID 28506312 DOI: 10.1186/S13058-017-0847-0  0.383
2017 Chalasani A, Ji K, Sameni M, Mazumder SH, Xu Y, Moin K, Sloane BF. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches. Methods in Molecular Biology (Clifton, N.J.). 1574: 215-225. PMID 28315254 DOI: 10.1007/978-1-4939-6850-3_16  0.458
2017 Jackson RM, Brock EJ, Shah S, Sameni M, Sloane BF, Li Q, Mattingly RR. Abstract B28: Induced expression of Sprouty4 in breast invasive ductal carcinoma cells inhibits ERK MAP kinase and reduces malignant phenotype Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-B28  0.429
2016 Ji K, Heyza J, Cavallo-Medved D, Sloane BF. Pathomimetic cancer avatars for live-cell imaging of protease activity. Biochimie. 122: 68-76. PMID 26375517 DOI: 10.1016/J.Biochi.2015.09.015  0.48
2016 Ji K, Zhao Z, Moin K, Xu Y, Sloane BF. Abstract B65: Live-cell imaging of 3D/4D parallel co-cultures of breast carcinoma cells and breast fibroblasts in tissue architecture and microenvironment engineering (TAME) chambers Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B65  0.471
2016 Tovar EA, Sameni M, Essenburg CJ, Chalasani A, Linklater ES, Cherba DM, Anbalagan A, Winn ME, Sloane BF, Graveel CR. Abstract B19: MET and IL6 signaling in triple-negative breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B19  0.375
2016 Brock EJ, Jackson R, Shah S, Li Q, Sameni M, Krawetz SA, Mao S, Sloane BF, Mattingly RR. Abstract 4560: Induced Sprouty4 expression in breast invasive ductal carcinoma cells downregulates ERK/MAPK activity and restores an epithelial-like phenotype Cancer Research. 76: 4560-4560. DOI: 10.1158/1538-7445.Am2016-4560  0.398
2015 Ramalho SD, Sharma R, White JK, Aggarwal N, Chalasani A, Sameni M, Moin K, Vieira PC, Turro C, Kodanko JJ, Sloane BF. Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound. Plos One. 10: e0142527. PMID 26562785 DOI: 10.1371/Journal.Pone.0142527  0.401
2015 Aggarwal N, Santiago AM, Kessel D, Sloane BF. Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer. Breast Cancer Research and Treatment. PMID 26502410 DOI: 10.1007/S10549-015-3618-6  0.355
2015 Sameni M, Tovar EA, Essenburg C, Chalasani A, Linklater ES, Borgman A, Cherba DM, Anbalagan A, Winn ME, Graveel CR, Sloane BF. Cabozantinib (XL184) inhibits growth and invasion of preclinical TNBC models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26432786 DOI: 10.1158/1078-0432.Ccr-15-0187  0.326
2015 Osuala KO, Sameni M, Shah S, Aggarwal N, Simonait ML, Franco OE, Hong Y, Hayward SW, Behbod F, Mattingly RR, Sloane BF. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. Bmc Cancer. 15: 584. PMID 26268945 DOI: 10.1186/S12885-015-1576-3  0.414
2015 Weber E, Barbulescu E, Medek R, Reinheckel T, Sameni M, Anbalagan A, Moin K, Sloane BF. Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies. Biological Chemistry. 396: 277-81. PMID 25205719 DOI: 10.1515/Hsz-2014-0191  0.343
2015 Ibrahim SA, Elghonaimy EA, El-Shinawi M, El-Halawany M, Nouh MA, El-Mamlouk T, Sloane BF, Mohamed MM. Abstract 430: MCP-1/CCL2 and IL-8 regulate proteolytic activity of triple negative inflammatory breast cancer via cathepsin B, ERK1/2, JAK1 and Src signaling pathways Cancer Research. 75: 430-430. DOI: 10.1158/1538-7445.Am2015-430  0.413
2014 Osuala KO, Sloane BF. Many Roles of CCL20: Emphasis on Breast Cancer. Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs. 2: 7-16. PMID 27631019 DOI: 10.14304/Surya.Jpr.V2N3.2  0.421
2014 Tan CD, Hobbs C, Sameni M, Sloane BF, Stutts MJ, Tarran R. Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures. The Journal of Physiology. 592: 5251-68. PMID 25260629 DOI: 10.1113/Jphysiol.2013.267286  0.307
2014 Aggarwal N, Sloane BF. Cathepsin B: multiple roles in cancer. Proteomics. Clinical Applications. 8: 427-37. PMID 24677670 DOI: 10.1002/Prca.201300105  0.496
2014 Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. Plos One. 9: e81126. PMID 24404125 DOI: 10.1371/Journal.Pone.0081126  0.393
2014 Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. The International Journal of Biochemistry & Cell Biology. 46: 138-47. PMID 24291763 DOI: 10.1016/J.Biocel.2013.11.015  0.407
2014 Bengsch F, Buck A, Günther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF, Reinheckel T. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene. 33: 4474-84. PMID 24077280 DOI: 10.1038/Onc.2013.395  0.538
2014 Shah S, Osuala K, Mao S, Li Q, Sloane B, Krawetz S, Mattingly RR. Abstract 3150: Exploring the role of Rap1Gap in the progression from DCIS to invasive breast carcinoma Cancer Research. 74: 3150-3150. DOI: 10.1158/1538-7445.Am2014-3150  0.458
2014 Kessel D, Aggarwal N, Sloane BF. Increased efficacy of photodynamic therapy via sequential targeting Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8931. DOI: 10.1117/12.2042421  0.357
2013 Rothberg JM, Bailey KM, Wojtkowiak JW, Ben-Nun Y, Bogyo M, Weber E, Moin K, Blum G, Mattingly RR, Gillies RJ, Sloane BF. Acid-mediated tumor proteolysis: contribution of cysteine cathepsins. Neoplasia (New York, N.Y.). 15: 1125-37. PMID 24204192 DOI: 10.1593/Neo.13946  0.729
2013 Ruffell B, Affara NI, Cottone L, Junankar S, Johansson M, DeNardo DG, Korets L, Reinheckel T, Sloane BF, Bogyo M, Coussens LM. Cathepsin C is a tissue-specific regulator of squamous carcinogenesis. Genes & Development. 27: 2086-98. PMID 24065739 DOI: 10.1101/Gad.224899.113  0.438
2013 Kaur H, Mao S, Shah S, Gorski DH, Krawetz SA, Sloane BF, Mattingly RR. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Review of Molecular Diagnostics. 13: 151-65. PMID 23477556 DOI: 10.1586/Erm.13.4  0.328
2013 Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ. Acidity generated by the tumor microenvironment drives local invasion. Cancer Research. 73: 1524-35. PMID 23288510 DOI: 10.1158/0008-5472.Can-12-2796  0.675
2013 Strand DW, DeGraff DJ, Jiang M, Sameni M, Franco OE, Love HD, Hayward WJ, Lin-Tsai O, Wang AY, Cates JM, Sloane BF, Matusik RJ, Hayward SW. Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration. The American Journal of Pathology. 182: 449-59. PMID 23219716 DOI: 10.1016/J.Ajpath.2012.10.007  0.364
2013 Caglič D, Repnik U, Jedeszko C, Kosec G, Miniejew C, Kindermann M, Vasiljeva O, Turk V, Wendt KU, Sloane BF, Goldring MB, Turk B. The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes. Biological Chemistry. 394: 307-16. PMID 23152404 DOI: 10.1515/Hsz-2012-0283  0.761
2013 Reichenbach G, Starzinski-Powitz A, Sloane BF, Doll M, Kippenberger S, Bernd A, Kaufmann R, Meissner M. PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms. Angiogenesis. 16: 223-33. PMID 23096928 DOI: 10.1007/S10456-012-9314-9  0.385
2013 Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Abstract B40: Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-B40  0.402
2012 Mullins SR, Sameni M, Blum G, Bogyo M, Sloane BF, Moin K. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins. Biological Chemistry. 393: 1405-16. PMID 23667900 DOI: 10.1515/Hsz-2012-0252  0.774
2012 Kaur H, Mao S, Li Q, Sameni M, Krawetz SA, Sloane BF, Mattingly RR. RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target. Plos One. 7: e50249. PMID 23236365 DOI: 10.1371/Journal.Pone.0050249  0.397
2012 Wojtkowiak JW, Rothberg JM, Kumar V, Schramm KJ, Haller E, Proemsey JB, Lloyd MC, Sloane BF, Gillies RJ. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Research. 72: 3938-47. PMID 22719070 DOI: 10.1158/0008-5472.Can-11-3881  0.678
2012 Sloane BF. On how mammary gland reprogramming metalloproteinases couple form with function. Cold Spring Harbor Perspectives in Biology. 4: a013474. PMID 22661591 DOI: 10.1101/Cshperspect.A013474  0.401
2012 Sameni M, Anbalagan A, Olive MB, Moin K, Mattingly RR, Sloane BF. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression Journal of Visualized Experiments : Jove. PMID 22371028 DOI: 10.3791/3661  0.481
2012 Moin K, Sameni M, Victor BC, Rothberg JM, Mattingly RR, Sloane BF. 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment. Methods in Enzymology. 506: 175-94. PMID 22341225 DOI: 10.1016/B978-0-12-391856-7.00034-2  0.802
2012 Al Sorkhy M, Ferraiuolo RM, Jalili E, Malysa A, Fratiloiu AR, Sloane BF, Porter LA. The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer. Bmc Cancer. 12: 45. PMID 22280365 DOI: 10.1186/1471-2407-12-45  0.399
2012 Withana NP, Blum G, Sameni M, Slaney C, Anbalagan A, Olive MB, Bidwell BN, Edgington L, Wang L, Moin K, Sloane BF, Anderson RL, Bogyo MS, Parker BS. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Research. 72: 1199-209. PMID 22266111 DOI: 10.1158/0008-5472.Can-11-2759  0.424
2012 Rothberg JM, Sameni M, Moin K, Sloane BF. Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochimica Et Biophysica Acta. 1824: 123-32. PMID 21854877 DOI: 10.1016/J.Bbapap.2011.07.025  0.731
2012 Rothberg JM, Bogyo MS, Sloane BF. Abstract 2467: Acidic pericellular pH increases contribution of cathepsin B to invasiveness of a human breast carcinoma cell line Cancer Research. 72: 2467-2467. DOI: 10.1158/1538-7445.Am2012-2467  0.737
2012 ElGhonaimy E, El-Shinawi M, Abd-El-Tawab R, Mamlouk TE, Sloane B, Mohamed M. Abstract P1-05-11: Biological characterization of tumor-associated leukocytes in positive and negative lymph node breast cancer patients Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-05-11  0.337
2012 Zhao C, Radulovic M, Jecmenica M, Patel S, Korsten MA, Sloane BF. Su1841 Interaction of DP1 and Cathepsin B in Colon Cancer Gastroenterology. 142: S-516-S-517. DOI: 10.1016/S0016-5085(12)61981-7  0.319
2012 Sameni M, Mullins SR, Moin K, Sloane BF, Osuala K. Modeling breast cancer progression in 4-D Breast Cancer Metastasis and Drug Resistance: Progress and Prospects. 177-188. DOI: 10.1007/978-1-4614-5647-6_10  0.737
2011 Victor BC, Anbalagan A, Mohamed MM, Sloane BF, Cavallo-Medved D. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Research : Bcr. 13: R115. PMID 22093547 DOI: 10.1186/Bcr3058  0.75
2011 Wojtkowiak JW, Sane KM, Kleinman M, Sloane BF, Reiners JJ, Mattingly RR. Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin. The Journal of Pharmacology and Experimental Therapeutics. 337: 65-74. PMID 21228063 DOI: 10.1124/Jpet.110.174573  0.358
2011 Nouh MA, Mohamed MM, El-Shinawi M, Shaalan MA, Cavallo-Medved D, Khaled HM, Sloane BF. Cathepsin B: a potential prognostic marker for inflammatory breast cancer. Journal of Translational Medicine. 9: 1. PMID 21199580 DOI: 10.1186/1479-5876-9-1  0.36
2011 Sloane B, Sameni M, Anbalagan A, Olive M, Shokoohi N, Moin K, Mattingly R. 4D MAME Models for Live-Cell Imaging of Interactions Between Breast Tumor Cells and Their Microenvironment Microscopy and Microanalysis. 17: 62-63. DOI: 10.1017/S1431927611001188  0.445
2010 El-Shinawi M, Abdelwahab SF, Sobhy M, Nouh MA, Sloane BF, Mohamed MM. Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach. Annals of Surgical Oncology. 17: 2677-84. PMID 20333554 DOI: 10.1245/S10434-010-1029-9  0.42
2010 Mohamed MM, Cavallo-Medved D, Rudy D, Anbalagan A, Moin K, Sloane BF. Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 25: 315-24. PMID 20110692 DOI: 10.1159/000276564  0.447
2010 Trivedi ER, Harney AS, Olive MB, Podgorski I, Moin K, Sloane BF, Barrett AG, Meade TJ, Hoffman BM. Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation. Proceedings of the National Academy of Sciences of the United States of America. 107: 1284-8. PMID 20080563 DOI: 10.1073/Pnas.0912811107  0.443
2010 Sameni M, Anbalagan A, Sloane BF. Abstract 2253: Proteases and cytokines in the transition from preinvasive DCIS to invasive breast carcinoma Cancer Research. 70: 2253-2253. DOI: 10.1158/1538-7445.Am10-2253  0.313
2009 Jedeszko C, Victor BC, Podgorski I, Sloane BF. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Research. 69: 9148-55. PMID 19920187 DOI: 10.1158/0008-5472.Can-09-1043  0.795
2009 Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis American Journal of Pathology. 175: 1255-1269. PMID 19700761 DOI: 10.2353/Ajpath.2009.080906  0.318
2009 Moin K, Schwartz D, Mullins SR, Sloane BF. Microarrays for protease detection in tissues and cells. Methods in Molecular Biology (Clifton, N.J.). 539: 49-57. PMID 19377971 DOI: 10.1007/978-1-60327-003-8_3  0.764
2009 Cavallo-Medved D, Rudy D, Blum G, Bogyo M, Caglic D, Sloane BF. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Experimental Cell Research. 315: 1234-46. PMID 19331819 DOI: 10.1016/J.Yexcr.2009.01.021  0.448
2009 Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research. 69: 2260-8. PMID 19276390 DOI: 10.1158/0008-5472.Can-07-5575  0.459
2009 Devetzi M, Scorilas A, Tsiambas E, Sameni M, Fotiou S, Sloane BF, Talieri M. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. Gynecologic Oncology. 112: 531-6. PMID 19110306 DOI: 10.1016/J.Ygyno.2008.10.030  0.343
2009 Sameni M, Cavallo-Medved D, Dosescu J, Jedeszko C, Moin K, Mullins SR, Olive MB, Rudy D, Sloane BF. Imaging and quantifying the dynamics of tumor-associated proteolysis Clinical and Experimental Metastasis. 26: 299-309. PMID 19082919 DOI: 10.1007/S10585-008-9218-7  0.807
2009 Mohamed M, El-Shinawi M, Cavallo-Medved D, Sobhy M, Nouh M, Abdelwahab S, Sloane B. Monocytes/macrophages and natural killer cells characterize the tumor microenvironment of inflammatory breast cancer in Egyptian patients. Cancer Research. 69: 1054. DOI: 10.1158/0008-5472.Sabcs-1054  0.35
2009 Tu C, Ortega-Cava CF, Chen G, Fernandes ND, Cavallo-Medved D, Sloane BF, Band V, Band H. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts (Cancer Research (2008) 68, (9147-9156)) Cancer Research. 69: 381. DOI: 10.1158/0008-5472.Can-69-1-Cor2  0.376
2008 Sameni M, Dosescu J, Yamada KM, Sloane BF, Cavallo-Medved D. Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells. Molecular Imaging. 7: 199-213. PMID 19123990  0.341
2008 Tu C, Ortega-Cava CF, Chen G, Fernandes ND, Cavallo-Medved D, Sloane BF, Band V, Band H. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. Cancer Research. 68: 9147-56. PMID 19010886 DOI: 10.1158/0008-5472.Can-07-5127  0.426
2008 Mohamed MM, Cavallo-Medved D, Sloane BF. Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer. Biological Chemistry. 389: 1117-21. PMID 18710343 DOI: 10.1515/Bc.2008.117  0.46
2008 Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF. Visualizing protease activity in living cells: from two dimensions to four dimensions. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 4.20. PMID 18551423 DOI: 10.1002/0471143030.Cb0420S39  0.778
2008 Li Q, Mullins SR, Sloane BF, Mattingly RR. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. Neoplasia (New York, N.Y.). 10: 314-29. PMID 18392133 DOI: 10.1593/Neo.07970  0.762
2008 Henkhaus RS, Roy UK, Cavallo-Medved D, Sloane BF, Gerner EW, Ignatenko NA. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia (New York, N.Y.). 10: 140-8. PMID 18283336 DOI: 10.1593/Neo.07817  0.412
2008 Moin K, Sameni M, Jedeszko C, Li Q, Olive MB, Mattingly RR, Sloane BF. Images of cleavage: Tumor proteases in action The Cancer Degradome: Proteases and Cancer Biology. 137-154. DOI: 10.1007/978-0-387-69057-5_8  0.382
2008 Schwartz DR, Moin K, Weber E, Sloane BF. The Hu/Mu protin chip: A custom dual-species oligonucleotide microarray for profiling degradome gene expression in tumors and their microenvironment The Cancer Degradome: Proteases and Cancer Biology. 37-47. DOI: 10.1007/978-0-387-69057-5_3  0.344
2007 Victor BC, Sloane BF. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function. Biological Chemistry. 388: 1131-40. PMID 17976005 DOI: 10.1515/Bc.2007.150  0.756
2007 Reisenauer A, Eickelberg O, Wille A, Heimburg A, Reinhold A, Sloane BF, Welte T, Bühling F. Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-β1-signaling and upregulation of cathepsin B Biological Chemistry. 388: 639-650. PMID 17552911 DOI: 10.1515/Bc.2007.072  0.411
2007 Schwartz DR, Moin K, Yao B, Matrisian LM, Coussens LM, Bugge TH, Fingleton B, Acuff HB, Sinnamon M, Nassar H, Platts AE, Krawetz SA, Linebaugh BE, Sloane BF. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment. Molecular Cancer Research : McR. 5: 443-54. PMID 17510311 DOI: 10.1158/1541-7786.Mcr-06-0337  0.373
2007 Calkins CC, Dosescu J, Day NA, Ren WP, Fridman R, Sloane BF, Moin K. Functional expression of recombinant human stefin A in mammalian and bacterial cells. Protein Expression and Purification. 52: 463-71. PMID 17208452 DOI: 10.1016/J.Pep.2006.11.020  0.35
2006 Sloane BF, Gillies RJ, Mohla S, Sogn JA, Menkens AE, Sullivan DC. I2 imaging: cancer biology and the tumor microenvironment. Cancer Research. 66: 11097-9. PMID 17114235 DOI: 10.1158/Aacr.Edb-Can-06-3102  0.412
2006 Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nature Reviews. Cancer. 6: 764-75. PMID 16990854 DOI: 10.1038/Nrc1949  0.438
2006 Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, Pozzi A, Carbone DP, Schwartz DR, Moin K, Sloane BF, Matrisian LM. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Research. 66: 7968-75. PMID 16912171 DOI: 10.1158/0008-5472.Can-05-4279  0.396
2006 Podgorski I, Sloane BF. Loss of caspase-8 in tumor cells: mechanism to overcome integrin-mediated death? Molecular Interventions. 6: 132-6. PMID 16809473 DOI: 10.1124/Mi.6.3.3  0.381
2006 Caserman S, Kenig S, Sloane BF, Lah TT. Cathepsin L splice variants in human breast cell lines. Biological Chemistry. 387: 629-34. PMID 16740135 DOI: 10.1515/Bc.2006.080  0.316
2006 Jane DT, Morvay L, Dasilva L, Cavallo-Medved D, Sloane BF, Dufresne MJ. Cathepsin B localizes to plasma membrane caveolae of differentiating myoblasts and is secreted in an active form at physiological pH. Biological Chemistry. 387: 223-34. PMID 16497156 DOI: 10.1515/Bc.2006.030  0.374
2006 Sloane BF, Sameni M, Podgorski I, Cavallo-Medved D, Moin K. Functional imaging of tumor proteolysis. Annual Review of Pharmacology and Toxicology. 46: 301-15. PMID 16402907 DOI: 10.1146/Annurev.Pharmtox.45.120403.095853  0.501
2006 Démoz M, Castino R, Follo C, Hasilik A, Sloane BF, Isidoro C. High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells. Protein Expression and Purification. 45: 157-67. PMID 16242956 DOI: 10.1016/J.Pep.2005.07.024  0.367
2005 Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nature Chemical Biology. 1: 203-9. PMID 16408036 DOI: 10.1038/Nchembio728  0.771
2005 Podgorski I, Linebaugh BE, Sameni M, Jedeszko C, Bhagat S, Cher ML, Sloane BF. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. Neoplasia (New York, N.Y.). 7: 207-23. PMID 15799821 DOI: 10.1593/Neo.04349  0.782
2005 Dong Z, Bonfil RD, Chinni S, Deng X, Trindade Filho JC, Bernardo M, Vaishampayan U, Che M, Sloane BF, Sheng S, Fridman R, Cher ML. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. The American Journal of Pathology. 166: 1173-86. PMID 15793297 DOI: 10.1016/S0002-9440(10)62337-1  0.375
2005 Cavallo-Medved D, Mai J, Dosescu J, Sameni M, Sloane BF. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. Journal of Cell Science. 118: 1493-503. PMID 15769846 DOI: 10.1242/Jcs.02278  0.469
2005 Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, Cavallo-Medved D, Sameni M, Dosescu J, Moin K. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Seminars in Cancer Biology. 15: 149-57. PMID 15652460 DOI: 10.1016/J.Semcancer.2004.08.001  0.458
2004 Jedeszko C, Sloane BF. Cysteine cathepsins in human cancer. Biological Chemistry. 385: 1017-27. PMID 15576321 DOI: 10.1515/Bc.2004.132  0.798
2004 Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller FR, Meschonat C, Li BD, Abreo F, Keppler D. Cystatin m: a novel candidate tumor suppressor gene for breast cancer. Cancer Research. 64: 6957-64. PMID 15466187 DOI: 10.1158/0008-5472.Can-04-0819  0.641
2004 Yan S, Sloane BF. Isolation of a novel USF2 isoform: repressor of cathepsin B expression. Gene. 337: 199-206. PMID 15276216 DOI: 10.1016/J.Gene.2004.05.005  0.387
2004 Caruso JA, Mathieu PA, Joiakim A, Leeson B, Kessel D, Sloane BF, Reiners JJ. Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents. Molecular Pharmacology. 65: 1016-28. PMID 15044632 DOI: 10.1124/Mol.65.4.1016  0.411
2004 DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. The American Journal of Pathology. 164: 1131-9. PMID 15039201 DOI: 10.1016/S0002-9440(10)63200-2  0.499
2004 Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene. 23: 2206-15. PMID 14676833 DOI: 10.1038/Sj.Onc.1207340  0.666
2003 Cavallo-Medved D, Dosescu J, Linebaugh BE, Sameni M, Rudy D, Sloane BF. Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. Neoplasia (New York, N.Y.). 5: 507-19. PMID 14965444 DOI: 10.1016/S1476-5586(03)80035-0  0.419
2003 Yan S, Jane DT, Dufresne MJ, Sloane BF. Transcription of cathepsin B in glioma cells: regulation by an E-box adjacent to the transcription initiation site. Biological Chemistry. 384: 1421-7. PMID 14669984 DOI: 10.1515/Bc.2003.157  0.365
2003 Sameni M, Dosescu J, Moin K, Sloane BF. Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Molecular Imaging. 2: 159-75. PMID 14649059 DOI: 10.1162/153535003322556903  0.502
2003 Podgorski I, Sloane BF. Cathepsin B and its role(s) in cancer progression. Biochemical Society Symposium. 263-76. PMID 14587299 DOI: 10.1042/Bss0700263  0.425
2003 Yan S, Sloane BF. Molecular regulation of human cathepsin B: implication in pathologies. Biological Chemistry. 384: 845-54. PMID 12887051 DOI: 10.1515/Bc.2003.095  0.422
2003 Roshy S, Sloane BF, Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Reviews. 22: 271-86. PMID 12785001 DOI: 10.1023/A:1023007717757  0.472
2003 Bervar A, Zajc I, Sever N, Katunuma N, Sloane BF, Lah TT. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biological Chemistry. 384: 447-55. PMID 12715895 DOI: 10.1515/Bc.2003.050  0.5
2003 Cavallo-Medved D, Sloane BF. Cell-surface cathepsin B: understanding its functional significance. Current Topics in Developmental Biology. 54: 313-41. PMID 12696754 DOI: 10.1016/S0070-2153(03)54013-3  0.474
2002 Jane DT, Morvay LC, Koblinski J, Yan S, Saad FA, Sloane BF, Dufresne MJ. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation. Biological Chemistry. 383: 1833-44. PMID 12553720 DOI: 10.1515/Bc.2002.207  0.372
2002 Mai J, Sameni M, Mikkelsen T, Sloane BF. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Biological Chemistry. 383: 1407-13. PMID 12437133 DOI: 10.1515/Bc.2002.159  0.459
2002 Scorilas A, Fotiou S, Tsiambas E, Yotis J, Kotsiandri F, Sameni M, Sloane BF, Talieri M. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biological Chemistry. 383: 1297-303. PMID 12437120 DOI: 10.1515/Bc.2002.146  0.374
2002 Jane DT, Morvay LC, Allen F, Sloane BF, Dufresne MJ. Selective inhibition of cathepsin B with cell-permeable CA074Me negatively affects L6 rat myoblast differentiation. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 80: 457-65. PMID 12234099 DOI: 10.1139/O02-134  0.39
2002 Koblinski JE, Dosescu J, Sameni M, Moin K, Clark K, Sloane BF. Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. The Journal of Biological Chemistry. 277: 32220-7. PMID 12072442 DOI: 10.1074/Jbc.M204708200  0.468
2002 Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung C, Weissleder R. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice Gastroenterology. 122: 406-414. PMID 11832455 DOI: 10.1053/Gast.2002.30990  0.356
2002 Guo M, Mathieu PA, Linebaugh B, Sloane BF, Reiners JJ. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. The Journal of Biological Chemistry. 277: 14829-37. PMID 11815600 DOI: 10.1074/Jbc.M108180200  0.392
2002 Jane DT, DaSilva L, Koblinski J, Horwitz M, Sloane BF, Dufresne MJ. Evidence for the involvement of cathepsin B in skeletal myoblast differentiation. Journal of Cellular Biochemistry. 84: 520-31. PMID 11813257 DOI: 10.1002/Jcb.10042  0.364
2002 Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. The Journal of Biological Chemistry. 277: 11533-8. PMID 11796715 DOI: 10.1074/Jbc.M109557200  0.361
2001 Sinha AA, Jamuar MP, Wilson MJ, Rozhin J, Sloane BF. Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis Prostate. 49: 172-184. PMID 11746262 DOI: 10.1002/Pros.1132  0.326
2001 Dong Z, Katar M, Linebaugh BE, Sloane BF, Berk RS. Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa European Journal of Biochemistry. 268: 6408-6416. PMID 11737195 DOI: 10.1046/J.0014-2956.2001.02607.X  0.329
2001 Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Sloane BF, Gleason DF. Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer. The Prostate. 48: 274-84. PMID 11536307 DOI: 10.1002/Pros.1107  0.358
2001 Premzl A, Puizdar V, Zavašnik-Bergant V, Kopitar-Jerala N, Lah TT, Katunuma N, Sloane BF, Turk V, Kos J. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases Biological Chemistry. 382: 853-857. PMID 11517941 DOI: 10.1515/Bc.2001.104  0.439
2001 Sameni M, Dosescu J, Sloane BF. Imaging proteolysis by living human glioma cells Biological Chemistry. 382: 785-788. PMID 11517931 DOI: 10.1515/Bc.2001.094  0.457
2001 Fernández PL, Farré X, Nadal A, Fernández E, Peiró N, Sloane BF, Shi GP, Chapman HA, Campo E, Cardesa A. Expression of cathepsins B and S in the progression of prostate carcinoma. International Journal of Cancer. Journal International Du Cancer. 95: 51-5. PMID 11241311 DOI: 10.1002/1097-0215(20010120)95:1<51::Aid-Ijc1009>3.0.Co;2-J  0.378
2001 Chen X, Ren W, Dong J, Xiao S, Sloane BF. Screening of gastric cancer cell sublines using the adhesion method Chinese Journal of Digestive Diseases. 2: 121-124. DOI: 10.1046/J.1443-9573.2001.00041.X  0.447
2000 Sameni M, Moin K, Sloane BF. Imaging proteolysis by living human breast cancer cells Neoplasia. 2: 496-504. PMID 11228542 DOI: 10.1038/Sj.Neo.7900116  0.439
2000 Ahram M, Sameni M, Qiu RG, Linebaugh B, Kirn D, Sloane BF. Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix Experimental Cell Research. 260: 292-303. PMID 11035924 DOI: 10.1006/Excr.2000.5031  0.405
2000 Hulkower KI, Butler CC, Linebaugh BE, Klaus JL, Keppler D, Giranda VL, Sloane BF. Fluorescent microplate assay for cancer cell-associated cathepsin b European Journal of Biochemistry. 267: 4165-4170. PMID 10866820 DOI: 10.1046/J.1432-1327.2000.01458.X  0.459
2000 Moin K, Demchik L, Mai J, Duessing J, Peters C, Sloane BF. Observing proteases in living cells Advances in Experimental Medicine and Biology. 477: 391-401. PMID 10849765 DOI: 10.1007/0-306-46826-3_40  0.798
2000 Mai J, Finley RL, Waisman DM, Sloane BF. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells Journal of Biological Chemistry. 275: 12806-12812. PMID 10777578 DOI: 10.1074/Jbc.275.17.12806  0.444
2000 Mai J, Waisman DM, Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression Biochimica Et Biophysica Acta - Protein Structure and Molecular Enzymology. 1477: 215-230. PMID 10708859 DOI: 10.1016/S0167-4838(99)00274-5  0.498
2000 Yan S, Berquin IM, Troen BR, Sloane BF. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma Dna and Cell Biology. 19: 79-91. PMID 10701774 DOI: 10.1089/104454900314591  0.33
2000 Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer Clinica Chimica Acta. 291: 113-135. PMID 10675719 DOI: 10.1016/S0009-8981(99)00224-7  0.513
2000 Shridhar R, Sloane BF, Keppler D. Inhibitors of Papain-Like Cysteine Peptidases in Cancer Handbook of Experimental Pharmacology. 140: 301-328. DOI: 10.1007/978-3-642-57092-6_16  0.589
1999 Demchik LL, Sameni M, Nelson K, Mikkelsen T, Sloane BF. Cathepsin B and glioma invasion. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 17: 483-94. PMID 10571410 DOI: 10.1016/S0736-5748(99)00011-8  0.809
1999 Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. European Journal of Biochemistry / Febs. 264: 100-9. PMID 10447678 DOI: 10.1046/J.1432-1327.1999.00582.X  0.418
1999 Frosch BA, Berquin I, Emmert-Buck MR, Moin K, Sloane BF. Molecular regulation, membrane association and secretion of tumor cathepsin B. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 107: 28-37. PMID 10190277 DOI: 10.1111/J.1699-0463.1999.Tb01523.X  0.447
1998 Bjarnadottir M, Wulff BS, Sameni M, Sloane BF, Keppler D, Grubb A, Abrahamson M. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells Journal of Clinical Pathology - Molecular Pathology. 51: 317-326. PMID 10193512 DOI: 10.1136/Mp.51.6.317  0.325
1998 Nishimura Y, Sameni M, Sloane BF. Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells Pathology and Oncology Research. 4: 283-296. PMID 9887359 DOI: 10.1007/Bf02905219  0.415
1998 Moin K, Cao L, Day NA, Koblinski JE, Sloane BF. Tumor cell membrane cathepsin B. Biological Chemistry. 379: 1093-9. PMID 9792442 DOI: 10.1515/Bchm.1998.379.8-9.1093  0.438
1998 Sinha AA, Quast BJ, Wilson MJ, Reddy PK, Gleason DF, Sloane BF. Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy. The Anatomical Record. 252: 281-9. PMID 9776083 DOI: 10.1002/(Sici)1097-0185(199810)252:2<281::Aid-Ar14>3.0.Co;2-J  0.37
1998 Calkins CC, Sameni M, Koblinski J, Sloane BF, Moin K. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy Journal of Histochemistry and Cytochemistry. 46: 745-751. PMID 9603786 DOI: 10.1177/002215549804600607  0.456
1998 Yan S, Sameni M, Sloane BF. Cathepsin B and human tumor progression Biological Chemistry. 379: 113-123. PMID 9524062  0.381
1997 Berquin IM, Ahram M, Sloane BF. Exon 2 of human cathepsin B derives from an Alu element Febs Letters. 419: 121-123. PMID 9426233 DOI: 10.1016/S0014-5793(97)01445-2  0.322
1997 Seyfried D, Han Y, Zheng Z, Day N, Moin K, Rempel S, Sloane B, Chopp M. Cathepsin B and middle cerebral artery occlusion in the rat Journal of Neurosurgery. 87: 716-723. PMID 9347980 DOI: 10.3171/Jns.1997.87.5.0716  0.321
1997 Sloane BF, Keppler D, Sameni M, Ahram M, Mikkelsen T. Cathepsinb: Regulation of expression and localization at sites of cell/matrk contact Faseb Journal. 11.  0.435
1996 Sloane BF. Suicidal tumor proteases Nature Biotechnology. 14: 826-827. PMID 9631001 DOI: 10.1038/Nbt0796-826B  0.328
1996 Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, Sloane BF. Tumor progression and angiogenesis: Cathepsin B & Co Biochemistry and Cell Biology. 74: 799-810. PMID 9164649 DOI: 10.1139/O96-086  0.501
1996 Ren WP, Fridman R, Zabrecky JR, Morris LD, Day NA, Sloane BF. Expression of functional recombinant human procathepsin B in mammalian cells. The Biochemical Journal. 319: 793-800. PMID 8920982 DOI: 10.1042/Bj3190793  0.423
1996 Berquin IM, Sloane BF. Cathepsin B expression in human tumors Advances in Experimental Medicine and Biology. 389: 281-294. PMID 8861022 DOI: 10.1007/978-1-4613-0335-0_35  0.481
1996 Keppler D, Sloane BF. Cathepsin B: Multiple enzyme forms from a single gene and their relation to cancer Enzyme and Protein. 49: 94-105. PMID 8797000  0.318
1996 Elliott E, Sloane BF. The cysteine protease cathepsin B in cancer Perspectives in Drug Discovery and Design. 6: 12-32. DOI: 10.1007/Bf02174043  0.467
1995 Sameni M, Elliott E, Ziegler G, Fortgens PH, Dennison C, Sloane BF. Cathepsin B and D are Localized at the Surface of Human Breast Cancer Cells. Pathology Oncology Research : Por. 1: 43-53. PMID 11173567 DOI: 10.1007/Bf02893583  0.467
1995 Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. Immunohistochemical localization of cathepsin B in neoplastic human prostate. The Prostate. 26: 171-8. PMID 7716081 DOI: 10.1002/Pros.2990260402  0.419
1995 Berquin IM, Cao L, Fong D, Sloane BF. Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene Gene. 159: 143-149. PMID 7622042 DOI: 10.1016/0378-1119(95)00072-E  0.327
1995 Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. Journal of Neurosurgery. 83: 285-90. PMID 7542317 DOI: 10.3171/Jns.1995.83.2.0285  0.459
1995 Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. The Anatomical Record. 241: 353-62. PMID 7538734 DOI: 10.1002/Ar.1092410309  0.331
1995 Berquin IM, Sloane BF. Cysteine proteases and tumor progression Perspectives in Drug Discovery and Design. 2: 371-388. DOI: 10.1007/Bf02172031  0.469
1994 Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. Journal of Cell Science. 107: 373-84. PMID 8207069  0.349
1994 Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 7: 76-81. PMID 8159656  0.315
1994 Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF. Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene Gene. 139: 163-169. PMID 8112600 DOI: 10.1016/0378-1119(94)90750-1  0.323
1994 Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Human Pathology. 25: 857-62. PMID 8088759 DOI: 10.1016/0046-8177(94)90003-5  0.459
1994 Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples American Journal of Pathology. 145: 1285-1290. PMID 7992833  0.387
1994 Rozhin J, Sameni M, Ziegler G, Sloane BF. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Research. 54: 6517-25. PMID 7987851  0.328
1994 Honn KV, Timár J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane BF. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Experimental Cell Research. 214: 120-30. PMID 7521840 DOI: 10.1006/Excr.1994.1240  0.48
1994 Campo E, Muñoz J, Miquel R, Palacín A, Cardesa A, Sloane BF, Emmert-Buck MR. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival American Journal of Pathology. 145: 301-309. PMID 7519824  0.378
1994 Visscher DW, Sloane B, Sakr W, Sameni M, Weaver D, Bouwman D, Crissman JD. Clinicopathologic Significance of Cathepsin B and Urokinase-type Plasminogen Activator Immunostaining in Colorectal Adenocarcinoma International Journal of Surgical Pathology. 1: 227-234. DOI: 10.1177/106689699400100403  0.451
1993 Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF. Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. The Anatomical Record. 235: 233-40. PMID 7678371 DOI: 10.1002/Ar.1092350207  0.361
1992 Moin K, Day NA, Sameni M, Hasnain S, Hirama T, Sloane BF. Human tumour cathepsin B. Comparison with normal liver cathepsin B. The Biochemical Journal. 285: 427-34. PMID 1637335 DOI: 10.1042/Bj2850427  0.325
1992 Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. The Biochemical Journal. 282: 273-8. PMID 1540143 DOI: 10.1042/Bj2820273  0.407
1992 Sloane BF, Rozhin J, Moin K, Ziegler G, Fong D, Muschel RJ. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Biological Chemistry Hoppe-Seyler. 373: 589-94. PMID 1515088 DOI: 10.1515/Bchm3.1992.373.2.589  0.351
1992 Boike G, Lah T, Sloane BF, Rozhin J, Honn K, Guirguis R, Stracke ML, Liotta LA, Schiffman E. A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells Melanoma Research. 1: 333-340. PMID 1422189 DOI: 10.1097/00008390-199201000-00004  0.327
1990 Sloane BF. Cathepsin B and cystatins: Evidence for a role in cancer progression Seminars in Cancer Biology. 1: 137-152. PMID 2103490  0.361
1990 Sloane BF, Moin K, Krepela E, Rozhin J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy Cancer and Metastasis Review. 9: 333-352. PMID 2097084 DOI: 10.1007/Bf00049523  0.471
1989 Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochimica Et Biophysica Acta. 993: 63-73. PMID 2804124 DOI: 10.1016/0304-4165(89)90144-X  0.393
1989 Rozhin J, Wade RL, Honn KV, Sloane BF. Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochemical and Biophysical Research Communications. 164: 556-61. PMID 2803319 DOI: 10.1016/0006-291X(89)91755-5  0.315
1989 Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloane BF. Degradation of laminin by human tumor cathepsin B Clinical &Amp; Experimental Metastasis. 7: 461-468. PMID 2785014 DOI: 10.1007/Bf01753666  0.463
1989 Fong D, Kartasova T, Sloane BF, Chan MMy. Bacterial expression of human cysteine proteinase inhibitor stefin A Febs Letters. 257: 55-58. PMID 2680606 DOI: 10.1016/0014-5793(89)81785-5  0.341
1988 Sloane BF, Rozhin J, Lah TT, Day NA, Buck M, Ryan RE, Crissman JD, Honn KV. Tumor cathepsin B and its endogenous inhibitors in metastasis. Advances in Experimental Medicine and Biology. 233: 259-68. PMID 3066154  0.325
1988 Cavanaugh PG, Sloane BF, Honn KV. Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis Haemostasis. 18: 37-46. PMID 3047022 DOI: 10.1159/000215781  0.41
1987 Menter DG, Hatfield JS, Harkins C, Sloane BF, Taylor JD, Crissman JC, Honn KV. Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells Clinical &Amp; Experimental Metastasis. 5: 65-78. PMID 3829498 DOI: 10.1007/Bf00116627  0.414
1987 Menter DG, Sloane BF, Taylor JD, Honn KV. A New in Vitro Model for Investigation of Tumor Cell-Platelet-Endothelial Cell Interactions and Concomitant Eicosanoid Biosynthesis Cancer Research. 47: 2425-2432. PMID 3552214  0.311
1987 Menter DG, Sloane BF, Steinert BW, Onoda J, Craig R, Harkins C, Taylor JD, Honn KV. Platelet enhancement of tumor cell adhesion to subendothelial matrix: Role of platelet cytoskeleton and platelet membrane Journal of the National Cancer Institute. 79: 1077-1090. PMID 3479634 DOI: 10.1093/Jnci/79.5.1077  0.38
1987 Grossi IM, Taylor JD, Honn KV, Kendall A, Sloane BF, Fitzgerald LA. Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins lb and llb/llla Proceedings of the Society For Experimental Biology and Medicine. 186: 378-383. PMID 3423021 DOI: 10.3181/00379727-186-3-Rc1  0.325
1987 Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV. Plasma membrane-associated cysteine proteinases in human and animal tumors. Experimental Cell Biology. 55: 209-24. PMID 3315769 DOI: 10.1159/000163420  0.45
1987 Honn KV, Menter DG, Onoda JM, Steinert BW, Diglio CA, Taylor JD, Sloane BF. Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism Advances in Prostaglandin, Thromboxane, and Leukotriene Research. 17: 981-985. PMID 2960216  0.326
1987 Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV. Plasma membrane-associated cysteine proteinases in human and animal tumors Pathobiology. 55: 209-224. DOI: 10.1159/000163420  0.342
1986 Onoda JM, Jacobs JR, Taylor JD, Sloane BF, Honn KV. Cisplatin and nifedipine: Synergistic cytotoxicity against murine solid tumors and their metastases Cancer Letters. 30: 181-188. PMID 3955540 DOI: 10.1016/0304-3835(86)90087-X  0.362
1986 Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV. Cathepsin B: Association with plasma membrane in metastatic tumors Proceedings of the National Academy of Sciences of the United States of America. 83: 2483-2487. PMID 3458210 DOI: 10.1073/Pnas.83.8.2483  0.356
1985 Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF, Honn KV. Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study Laboratory Investigation. 53: 470-478. PMID 4046557  0.351
1985 Cavanaugh PG, Sloane BF, Bajkowski AS, Taylor JD, Honn KV. Purification and characterization of platelet aggregating activity from tumor cells: Copurification with procoagulant activity Thrombosis Research. 37: 309-326. PMID 3975874 DOI: 10.1016/0049-3848(85)90019-2  0.314
1985 Honn KV, Onoda JM, Pampalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA, Sloane BF. Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo Biochemical Pharmacology. 34: 235-241. PMID 3966924 DOI: 10.1016/0006-2952(85)90130-3  0.382
1985 Ryan RE, Sloane BF, Crissman JD, Honn KV. Cathepsin B-like Activity in Viable Tumor Cells Isolated from Rodent Tumors Cancer Research. 45: 3636-3641. PMID 3893687  0.394
1984 Honn KV, Onoda JM, Diglio CA, Carufel MM, Taylor JD, Sloane BF. Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine Clinical &Amp; Experimental Metastasis. 2: 61-72. PMID 6543691 DOI: 10.1007/Bf00132307  0.383
1984 Sloane BF, Honn KV. Cysteine proteinases and metastasis Cancer and Metastasis Review. 3: 249-263. PMID 6093995 DOI: 10.1007/Bf00048388  0.485
1984 Sloane BF, Sadler JG, Evens C. Cathepsin B-like cysteine proteinases and tumor metastasis Cancer Bulletin. 36: 196-200.  0.329
1983 Honn KV, Onoda JM, Diglio CA, Sloane BF. Calcium Channel Blockers: Potential Antimetastatic Agents Proceedings of the Society For Experimental Biology and Medicine. 174: 16-19. PMID 6634703 DOI: 10.3181/00379727-174-1-Rc2  0.389
1983 Honn KV, Menter D, Cavanaugh PG, Neagos G, Moilanen D, Taylor JD, Sloane BF. A review of prostaglandins and the treatment of tumor metastasis Acta Clinica Belgica. 38: 53-67. PMID 6405568 DOI: 10.1080/22953337.1983.11718906  0.413
1983 Cavanaugh PG, Sloane BF, Bajkowski AS, Gasic GJ, Gasic TB, Honn KV. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles Clinical &Amp; Experimental Metastasis. 1: 297-307. PMID 6400436 DOI: 10.1007/Bf00121192  0.387
1983 Honn KV, Busse WD, Sloane BF. Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis Biochemical Pharmacology. 32: 1-11. PMID 6338880 DOI: 10.1016/0006-2952(83)90644-5  0.466
1982 Sloane BF, Honn KV, Taylor JD, Sadler JG, Turner WA, Kimpson JJ. Cathepsin B Activity in B16 Melanoma Cells: A Possible Marker for Metastatic Potential Cancer Research. 42: 980-986. PMID 7059993  0.401
1982 Honn KV, Cavanaugh P, Evens C, Taylor JD, Sloane BF. Tumor cell-platelet aggregation: Induced by cathepsin B-like proteinase and inhibited by prostacyclin Science. 217: 540-542. PMID 7046053 DOI: 10.1126/Science.7046053  0.401
1981 Sloane BF, Dunn JR, Honn KV. Lysosomal cathepsin B: Correlation with metastatic potential Science. 212: 1151-1153. PMID 7233209 DOI: 10.1126/Science.7233209  0.483
1980 James‐Kracke MR, Sloane BF, Shuman H, Karp R, Somlyo AP. Electron probe analysis of cultured vascular smooth muscle Journal of Cellular Physiology. 103: 313-322. PMID 7440638 DOI: 10.1002/Jcp.1041030217  0.474
1979 Scarpa A, Valliéres J, Sloane B, Somlyo AP. Smooth muscle mitochondria. Methods in Enzymology. 55: 60-5. PMID 459858 DOI: 10.1016/0076-6879(79)55009-5  0.534
1979 James-Kracke MR, Sloane BF, Shuman H, Somlyo AP. Lysosomal composition in cultured vascular smooth muscle cells: Electron probe analysis Proceedings of the National Academy of Sciences of the United States of America. 76: 6461-6465. PMID 293733 DOI: 10.1073/Pnas.76.12.6461  0.49
1978 Sloane BF, Scarpa A, Somlyo AP. Vascular smooth muscle mitochondria: Magnesium content and transport Archives of Biochemistry and Biophysics. 189: 409-416. PMID 708060 DOI: 10.1016/0003-9861(78)90228-X  0.537
1977 Sloane BF, Bird JW. Effect of ovarian hormones on lysosomal acid hydrolase activities in rat myometrium. The American Journal of Physiology. 232: E423-31. PMID 557904  0.573
Show low-probability matches.